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Abstract
Background Cardiac surgery and sternotomy are proce-
dures accompanied by substantial postoperative pain which
is challenging to treat. In general, intravenous (IV) opioids
are used in the immediate postoperative phase, followed by
oral opioids. Oral opioids are easier to use and generally
less expensive. Our goal was thus to determine whether a
new opioid preparation provides adequate analgesia after
sternotomy. In particular, we tested the primary hypothesis
that total opioid use (in morphine equivalents) is not
greater with oral opioid compared with patient-controlled
IV morphine. Our secondary hypothesis was that analgesic
efficacy is similar with oral and IV opioids.
Methods A total of 51 patients having elective cardiac
surgery were enrolled in this study. After rapid postoper-
ative respiratory weaning, the patients were randomised
into one of two groups receiving different types of anal-
gesia: oral Targin (a combination of oxycodone–hydro-
chloride and the opioid antagonist naloxone hydrochloride-
dihydrate) or patient-controlled IV morphine. Pain score
(visual analogue scale), sedation (Ramsey score), respira-
tory rate and side effects were assessed at 3, 5, 7, 9 and
11 h after surgery, and every 6 h throughout the third
postoperative evening.
Results The total opioid dose in morphine equivalent
doses was significantly lower with oral opioid than with IV
morphine (adjusted geometric means [95 % confidence
interval]: 34 [29; 38] vs. 69 [61; 78] mg, respectively). Pain
scores were similar in each group.
Conclusions Analgesic quality was comparable with oral
and IV opioids, suggesting that postoperative pain even
after very painful procedures can be sufficiently managed
with oral opioids.
Keywords Anaesthesia  Opioid  Pain  Surgery
Introduction
Skin incisions, intraoperative tissue retraction and dissec-
tion, intravasal cannulations and drainages, sternotomy and
pericardiotomy all contribute to intense pain after cardiac
surgery [1, 2]. As might be expected, the treatment of such
pain remains challenging [1]. Poorly controlled thoracic
pain may contribute directly or indirectly to postopera-
tive complications, including myocardial ischaemia,
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hypoventilation and atelectasis, delayed return of gastro-
intestinal function and decreased mobility [2, 3]. There is
also a strong association between prolonged acute pain and
subsequent development of persistent incisional pain [4].
Opioids are the most commonly used medications for
the treatment of acute severe postoperative pain, and their
analgesic efficacy is undisputed. Opioids are usually given
intravenously during the initial postoperative days and then
continued orally. Patient-controlled analgesia (PCA) is
widely used and effective [4], but requires trained staff and
expensive equipment [5].
Once patients tolerate oral medications, oral adminis-
tration is preferred because it is convenient, non-invasive,
easier and generally less expensive [2]. Early postoperative
administration of oral opioids would therefore facilitate
analgesic management and presumably reduce healthcare
costs. The aim of our study was to determine whether a oral
opioid preparation, Targin (a combination of oxycodone
hydrochloride and the opioid antagonist naloxone hydro-
chloride dihydrate), provides postoperative analgesia
comparable to that provided by IV PCA. In particular, we
tested the primary hypothesis that total opioid use (in
morphine equivalents) is smaller with oral opioid com-
pared with PCA IV morphine.
Methods
This study is registered at clinicaltrials.gov (NCT018-
16581) and was conducted in the Department of Cardio-
thoracic and Vascular Anaesthesia and Intensive Care
Medicine at the Medical University of Vienna. With
approval from the Ethics Committee of the Medical Uni-
versity Vienna and after obtaining written informed con-
sent from prospective patients, we enrolled 51 patients
scheduled for elective conventional on-pump cardiac sur-
gery requiring a median sternotomy between July 2011 and
May 2012.
Patients were randomly allocated to one of two treat-
ment arms: postoperative oral opioid (oral group) or IV
PCA morphine (PCA group). Targin is a controlled-release
oral medication that consists of a fixed ratio of two drugs
per tablet: the opioid oxycodone hydrochloride (20 mg)
and the opioid antagonist naloxone hydrochloride dihy-
drate (10 mg). Oxycodone is a potent semi-synthetic opioid
analgesic that has been in clinical use since 1917 for the
treatment of severe pain [6]. It is effective in severe chronic
pain, whether nociceptive, cancer-related or neuropathic
pain [7]. Naloxone is a potent l-receptor antagonist.
All patients had American Society of Anesthesiologists
(ASA) physical status scores of 3 or 4, were aged
18–90 years and were expected to be extubated within 4
postoperative hours. Exclusion criteria were chronic use of
opioids, tranquilizers or pain medications within 3 months;
hypersensitivity to opioids; use of monoamine oxidase
inhibitors in the 2 weeks before surgery; alcohol or drug
abuse; renal dysfunction (glomerular filtration rate of \30
ml/min/1.73 m2 or need for dialysis); liver dysfunction
defined as Child–Pugh Score 7–15; ejection fraction of
\40 %; malabsorption syndrome; neurologic or cognitive
dysfunction; pregnancy; severe respiratory depression;
severe chronic obstructive pulmonary disease; severe
bronchial asthma; non-opioid induced paralytic ileus; his-
tory of seizures.
Based on our observations in recent years at the Medical
University of Vienna, we noted that patients recovering
from sternotomy required about 50 ± 15 (standard devia-
tion, SD) mg IV morphine sulphate during the first 3
postoperative days. We thus estimated that 72 patients
would provide 80 % power at an alpha level of 5 % based
on a 20 % treatment effect. Because cardiac surgery is a
difficult study setting and there was thus substantial
potential for patients dropping out, our aim was to enrol
100 patients.
Protocol
Patients were premedicated with up to 7.5 mg midazolam.
General anaesthesia was induced with fentanyl at approx-
imately 3 lg/kg, propofol at approximately 1.5 mg/kg and
rocuronium at approximately 0.6 mg/kg. General anaes-
thesia was maintained with sevoflurane combined with
0.2–0.4 lg/kg/min remifentanil as clinically necessary. At
30 min before the anticipated end of surgery, patients were
given 1 g paracetamol intravenously. At the end of surgery,
patients were transferred to the intensive care unit (ICU),
still intubated and ventilated, and remifentanil was reduced
to 0.05 lg/kg/min. Remifentanil was discontinued 3 h after
surgery. Patients were thereafter given 1 g paracetamol
intravenously at 6-h intervals throughout the first 3 post-
operative days.
Using a ‘‘fast track’’ approach, patients were weaned
from mechanical ventilation and extubated as quickly as
possible. At 2 h after extubation, patients were tested for
the ability to swallow. Patients were only randomised if
swallowing was successful, and the swallowing test was
assigned time zero. Randomisation (1:1) without stratifi-
cation was based on computer-generated codes that were
kept in sequentially numbered opaque envelopes.
Patients assigned to the PCA group were given a basal
rate of 0.3 mg morphine per hour. The demand dose was a
1 mg bolus with a 5-min lockout, but no other hourly limit.
Patients assigned to the oral group were given 20 mg
Targin tablets at 12-h intervals, corresponding to a daily
dose of 36 mg oxycodone. On their demand or when visual
analogue scores (see below) exceeded 30 mm, patients
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were given an additional 5 mg oxycodone hydrochloride,
which was repeated as necessary at 30-min intervals.
Measurements
Patients were instructed on the use of the visual analogue
scale (VAS) for measuring pain and on the PCA pump the
day before surgery. The VAS was evaluated using a slide
rule which ranged from 0 mm (no pain) to 100 mm (worst
pain) [8, 9]. Three hours after extubation, patients rated
their pain using the VAS. We simultaneously recorded
impairment of consciousness using the Ramsay Sedation
Scale [10], spontaneous respiratory rate and potential side
effects, including nausea, vomiting, anorexia, dizziness,
headache and itching. The VAS, Ramsey sedation score
[10], spontaneous respiratory rate, time of first defecation
and potential side effects were also assessed at 3, 5, 7, 9,
and 11 h after end of surgery. The same measurements
were also made every 6 h throughout the third postopera-
tive evening.
Statistical analysis
All postoperative opioid administrations were converted to
IV morphine equivalent doses, with 20 mg of Targin being
considered equivalent to 18 mg oral oxycodone and,
therefore, to 9 mg of IV morphine [11–15].
Although the assignment of patients to the oral or PCA
group was random, the risk of chance imbalance on
potential confounding variables nonetheless existed due to
the relatively small sample size of our study. We thus
initially compared the randomised groups with respect to
balance on baseline and intraoperative characteristics.
Balance was assessed using standard univariable summary
statistics as well as standardised difference scores [24]. The
standardised difference score is an index that measures the
magnitude of difference between groups on baseline vari-
ables; it is calculated as the difference in means, mean
rankings or proportions divided by a common measure of
standard deviation across the two groups. Any baseline or
intraoperative characteristic displaying imbalance as char-
acterised by a standardised difference of [0.1 in absolute
value was considered for adjustment in all analyses com-
paring randomised groups.
To evaluate the primary hypothesis comparing the ran-
domised groups on total IV morphine equivalent dose, we
developed a linear regression model in which we applied
the logarithmic transformation to morphine equivalent
doses prior to modelling in order to model percentage
differences between groups. Any imbalanced baseline
variables (as per the criterion above) were considered for
entry into the model; backward stepwise variable selection,
with a selection criteria set conservatively at P \ 0.30, was
used to obtain the final multivariable model. The Wald test
for regression model coefficients was employed to test for
significance of treatment effect with Type I error rate set at
5 %.
To study the effect of oral opiate medication on pain
score we used a linear mixed model [16]. This model
allows for estimation of mean pain scores as a function of
postoperative time while adjusting confidence interval (CI)
estimates to accommodate for the correlation present
among repeated pain measurements obtained from a given
patient (we used a spatial power correlation structure,
which assumes a greater degree of correlation among pain
score measurements close together in time than among
measurements distant in time from one another). Similarly,
a linear mixed model was used to compare two randomised
groups based on the rate of spontaneous breathing.
Regarding the impairment of consciousness in the
Ramsay sedation scale, we only observed levels I, II and III
during all postoperative days with 63 % of the times
detecting level II and 36 % of the times detecting level III.
To assess the level of sedation in the exploratory groups we
transformed data into a binary variable (i.e. sedation score
of III vs. I/II). We then used a logistic mixed model with
adjustment for the correlation among repeated measures as
for pain scores.
Likely complications (nausea, vomiting, anorexia, diz-
ziness, headache and itching) were summarised into a
collapsed composite binary outcome (i.e. any vs. none).
The odds of experiencing one or more complications were
compared between oral and control groups using logistic
regression analysis (adjusting for the same factors as in the
primary analysis). Incidence of each individual complica-
tion and constipation difficulties were also reported for
each group.
Wald tests for regression model coefficients were used
for each of the secondary hypotheses; the Bonferroni cor-
rection was applied in order to control the overall Type I
error rate at 5 % for these secondary hypothesis tests [17].
R statistical software version 2.15.2 for the 64-bit Unix
operating system (The R Foundation for Statistical Com-
puting, Vienna, Austria) was used for all analysis (Fig. 1).
Results
The study enrolment was discontinued after 51 patients
when the principal investigator (KR) moved from the
University of Vienna to the University of Zurich. One of
the 51 patients requested exclusion from the study 54 h
after randomisation to the oral opioid group because of
subjective discomfort. Thus, a total of 50 patients were
included in the analysis, of whom 24 were given oral
opioids and 26 were given IV opioids.
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Baseline and intraoperative characteristics of the two
study groups are shown in Table 1. Patients randomised to
oral group, by chance, were slightly older, more likely to
be female, had a lower ASA physical status, had a lower
body mass index (BMI), underwent shorter surgery and
were mechanically ventilated slightly longer. We thus
adjusted for these factors in all analyses.
Outcome variables are summarised in Table 2. As for the
primary outcome, backward stepwise variable selection led
to a final multivariable model with the following baseline
potential confounding variables: age, BMI, type of surgery
and duration of surgery. Adjusting for these variables, we
found that the total IV morphine equivalent dose was sig-
nificantly lower for oral group than PCA group (Wald test
P \ 0.001). That adjusted geometric mean [95 % CI]
morphine equivalent doses were 34 [29; 38] mg and 69 [61;
78] mg for the oral and IV groups, respectively, and the
corresponding ratio [95 % CI] of geometric means was 0.49
[0.41; 0.58]. The unadjusted observed median [1st quartile;
3rd quartile] morphine equivalent doses were 32 [29; 34]
and 84 [45; 95] mg for the oral and IV groups, respectively.
Adjusted VAS pain score estimates as a function of
postoperative time for each group are shown in Fig. 2. As
shown on this figure, estimates appeared to be slightly
higher in the oral group than in the PCA group. However,
we found no significant time-dependence of the treatment
effect in our sample (group–time interaction F test
P = 0.99) and found no overall treatment effect of oral
opioids after removal of the group–time interaction
(adjusted difference in mean VAS pain scores [98.7 % CI]
of 3.4 [-4.3, 11.2] points comparing the oral group to the
PCA group; Wald test P = 0.37, using a significance cri-
terion of 0.05/4 = 0.0125; Table 2). Adjusted mean
[98.7 % confidence interval] VAS pain scores were 18 [13,
22] points and 14 [10, 18] points for the oral and IV groups,
respectively; the unadjusted observed time-weighed mean
[98.7 % confidence interval] pain scores were 17 [0, 44]
and 14 [0, 41] points for the oral and IV groups.
Assessed for eligibility (n = 79) 
Excluded (n = 28) 
Not meeting inclusion criteria (n = 4) 
Declined to participate (n = 3) 
Unsuccessful swallow attempt (n = 2) 
Other reasons (n = 19) 
Analysed  (n = 26) 
• Excluded from analysis (n = 0) 
Lost to follow-up (n = 0) 
Discontinued intervention (n = 0) 
Allocated to intervention – morphine PCA (n = 
26) 
• Received allocated intervention (n = 26) 
Lost to follow-up (n = 0) 
Discontinued intervention (n = 1)  
• Patient declined to participate after receiving 
   first intervention due to subjective 
   discomfort 
Allocated to intervention – oral Targin (n = 25) 
• Received allocated intervention (n = 25) 
• Did not receive allocated intervention (n = 0) 
Analysed  (n = 24) 
•  Excluded from analysis (n = 1) 
Allocation
Analysis
Follow-Up 
Randomised (n=51 )
Enrollment
Fig. 1 Consort flow chart
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For the other secondary outcomes (Table 2), we found
no significant group effect on either the spontaneous
respiratory rate or the likelihood of being deeply sedated
after covariate adjustment (Wald test P = 0.79 and
P = 0.85, respectively). Likewise, the odds of side effects
did not differ significantly (adjusted odds ratio [98.7 %
confidence interval] comparing oral to IV groups: 0.27
[0.05; 1.48]; Wald test P = 0.06). The side effects are
summarised in Table 3. For the given sample, patients
given oral opioids had fewer side effects except for vom-
iting. The observed median length of ICU stay [1st quartile,
3rd quartile] was 1 [1, 2] days for both groups, while
hospital duration was 8.5 [8, 12] days for the oral group
and 9 [8, 11] days for the PCA group.
Discussion
Cardiac surgery with median sternotomy provokes consid-
erable postoperative pain. Our results indicate that the
administration of oral opioids provided comparable anal-
gesia to IV PCA, while actually reducing overall opioid
dose in morphine equivalents. Although our study was not
powered for differences in side effects, based on our results,
it appears that reduced opioid dose with oral administration
may also reduce opioid-induced complications.
The oral administration of controlled-released tablets
is not generally recommended during the initial postop-
erative day because of concerns about delayed drug
absorption in the presence of decreased gastric emptying
Table 1 Summary of baseline
and intraoperative patient
characteristics
Data are presented as the mean
± standard deviation (SD), or as
the number (N) with the
percentage in parenthesis, as
appropriate
a Patients randomised to the
‘‘oral group’’ received
postoperative oral opioid
(Targin tablets); patients
randomised to the ‘‘Intravenous
group’’ received patient-
controlled analgesia as
intravenous (IV) morphine
b These factors were used for
adjustment in our main analysis
Factor Intravenous
group (N = 26)a
Oral group
(N = 24)a
Standardised
difference score
Female gender (vs. male)b 4 (15.4) 6 (25) 0.24
Age (years)b 63 ± 14 67 ± 15 0.27
American Society of Anesthesiologists’ physical statusb
II 8 (30.8) 4 (16.7) 0.34
III 18 (69.2) 20 (83.3)
Height (cm) 173 ± 9 170 ± 6 -0.42
Weight (kg) 85 ± 14 79 ± 12 -0.46
Body mass index (kg/m2)b 28 ± 3 27 ± 4 -0.27
Type of surgeryb
Bypass 16 (61.5) 15 (62.5) -0.02
Valve 10 (38.5) 9 (37.5)
Duration of surgery (h)b 4.6 ± 0.9 4.3 ± 0.7 -0.36
Duration of anesthesia (h)b 6.1 ± 1.1 5.9 ± 0.9 -0.19
Duration of ventilation (h)b 12.2 ± 3.8 13.4 ± 3.8 0.33
Table 2 Major outcomes
Outcome Comparison (oral vs. intravenous) Estimate [95 % CI]a Pb
Primary outcome
Opioid equivalent dose Adjusted ratio of geometric means 0.49 [0.41; 0.58] \0.001
Secondary outcome
VAS Pain Score Adjusted difference of means 3.44 [-4.29; 11.17] 0.37
Ramsay sedation scale level Adjusted odds ratio 0.95 [0.45; 1.99] 0.85
Spontaneous breathing rate Adjusted difference of means 0.17 [-1.89; 2.22] 0.79
Side effectsc Adjusted odds ratio 0.27 [0.05; 1.48] 0.06
CI Confidence interval
Data are presented as oral vs. intravenous, adjusted for age, body mass index, type of surgery and duration of surgery using either linear
regression (wherever differences in means or ratio of geometric means are reported) or logistic regression (wherever odds ratios are reported)
a Confidence limits for the secondary hypotheses reflect the Bonferroni adjustment for multiple comparisons in order to maintain an overall 5 %
Type I error rate
b P is from the Wald tests of regression coefficients. Significance criterion of 0.05 for primary outcome and 0.05/4 = 0.0125 for the secondary
outcomes
c Side effects is a composite binary outcome equal to ‘‘yes’’ if any of the following were present: nausea, vomiting, anorexia, dizziness, headache
and itching
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[18, 19]. Based on the results of their study, Valtola et al.
[20] concluded that the absorption of oral drugs is low
within the first 48 h after cardiac surgery. However, we
found oral administration to be effective, which is con-
sistent with other studies in patients undergoing non-
cardiac operations [5, 21]. For example, Duellman et al.
[22] reported that multimodal, pre-emptive analgesia,
including oxycodone, is associated with lower opioid
consumption and shorter hospitalisation after orthopaedic
surgery. Similarly, Rothwell et al. [5] reported that oral
analgesics were comparable to intravenous morphine
after total hip replacement.
A common complication of opioids is paralytic ileus
which can occur with either oral or intravenous adminis-
tration [2]. Ileus, however, is most common after gastro-
intestinal surgery—especially after colon resection. We did
not observe ileus in any of our patients, suggesting that the
complication is relatively rare in cardiac patients. The
incidence of opioid-induced respiratory and haemodynamic
effects depends on the definition, the route of administra-
tion and the specific opioid given [23]. However, Ramsey
sedation scores and spontaneous respiratory rates were
comparable in both of our study groups.
The major limitation of our study is its low power for
detecting clinically important effects of oral opioid
administration on complications, a limitation that was
worsened when the study was stopped for administrative
reasons after only half the planned enrolment. Furthermore,
the study was not double-blinded for organisational and
administrative reasons. It is thus possible that the opioid
administration route influenced patients’ subjective
responses, including pain perception. However, to the
extent that pain perception was biased by administration
Fig. 2 Estimated mean visual analogue score (VAS) for pain for each
of the randomised groups [I.V. intravenous group receiving IV
morphine, Oral group receiving postoperative oral opioid (Targin
tablets)] as a function of postoperative time. Recovery time is
expressed as hours after extubation. 6 am POD 1, 6 pm POD 1 The
06:00 am and 06:00 pm of the first postoperative day, respectively,
POD2 second postoperative day, POD3 third postoperative day.
Error bars extend to two standard errors (SE) of the mean (SE
estimated via the respective linear mixed model). Error bars below 0
were truncated. No group–time interaction was found for the pain
score (F test P = 0.99), although estimates displayed come from the
model with interaction. Estimates are adjusted for age, body mass
index, type of surgery and duration of surgery
Table 3 Incidence of complications
Complication Intravenous group (N = 26) Oral group (N = 24)
Nausea 8 (31) 3 (12)
Vomiting 3 (12) 5 (21)
Anorexia 8 (31) 4 (17)
Dizziness 11 (42) 6 (25)
Headache 5 (19) 1 (4)
Itching 1 (4) 1 (4)
First Defecation (days, 0 = none during study period)
0 15 (58) 11 (46)
1 0 (0) 2 (8)
2 2 (8) 4 (17)
3 9 (35) 7 (29)
Data are presented as the number of patients with the percentage in
parenthesis
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route, one might expect that most patients would consider
intravenous treatment to be more potent.
In summary, this is the first randomised trial of exclu-
sive oral versus IV opioids for treatment of pain after
sternotomy. The analgesic quality was comparable with
each approach, suggesting that oral opioids can be suffi-
cient even after very painful procedures and at an early
stage after surgery.
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